Piramal Pharma Limited Announces Results for Q2 and H1 FY27
· prnewswire.com · popularity 16/100 · 0 similar stories today
Read the original at prnewswire.com →
Summary
MUMBAI, India, Oct. 27, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September...
Found in: PR Newswire. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 18.